Myo, E. and Mohandas, C. (2025) “Comparison of subcutaneous GLP-1 receptor agonists, semaglutide and dulaglutide, on HbA1c and weight loss outcomes: A systematic review”, Advanced Journal of Professional Practice, 5(1), pp. 45–46. doi: 10.22024/UniKent/03/ajpp.1365.